Q4 2025 Holdings
Filed 2026-02-17 | 30 holdings | $147.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $25.7M | 637,095 | 17.5% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $24.5M | 83,036 | 16.6% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $19.7M | 89,145 | 13.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $12.8M | 1,052,995 | 8.7% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $8.3M | 3,410,402 | 5.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $6.6M | 84,477 | 4.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.9M | 1,093,300 | 4.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $4.9M | 29,008 | 3.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.5M | 25,878 | 3.1% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $4.1M | 4,851 | 2.8% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $4.0M | 178,415 | 2.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.0M | 333,258 | 2.7% |
| Minerva Neurosciences(NERV) | COM NEW | 603380205 | $2.9M | 709,500 | 1.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $2.5M | 282,732 | 1.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.5M | 454,827 | 1.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $2.1M | 80,143 | 1.4% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $2.0M | 101,777 | 1.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $1.4M | 150,906 | 1.0% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $1.3M | 16,377 | 0.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.1M | 2,296 | 0.8% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.1M | 143,446 | 0.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $828.6K | 20,000 | 0.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $781.3K | 59,280 | 0.5% |
| Sutro Biopharma Inc(STRO) | COM | 869367201 | $780.4K | 67,451 | 0.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $688.5K | 16,708 | 0.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $669.9K | 8,411 | 0.5% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $667.8K | 30,000 | 0.5% |
| Pasithea Therapeutics Corp(KTTA) | COM NEW | 70261F202 | $580.5K | 450,000 | 0.4% |
| Unicycive Therapeutics Inc(UNCY) | COM | 90466Y202 | $346.1K | 59,985 | 0.2% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $30.0K | 90,832 | 0.0% |